ADAMTS13 and thrombotic thrombocytopenic purpura: The latter group, referred in our study as “suspected non-TTP TMA” may include various conditions such as STEC-HUS, CM-TMA, and other disorders with TMA-like features for which physicians considered ADAMTS-13 activity testing clinically relevant.